Together with the early findings that humans with genetic deficiency of CETP had elevated levels of HDL and decreased levels of LDL [118, 119], the development of CETP inhibitors as a potential treatment of cardiovascular disease has garnered great interest. This evidence concerns the gene CETP and cardiovascular disorder.